Covaxin was found to have 78% efficacy against COVID19 of any severity, 14 or more days after the second dose. Moreover, the WHO statement also remarked that the Covaxin is extremely suitable for low- and middle-income countries due to easy storage requirements. 📰 Covaxin, Bharat Biotech s COVID-19 Vaccine, Gets WHO Approval for Emergency Use Listing.